Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enfusion Inc Cl A (NY: ENFN ) 9.300 -0.030 (-0.32%) Official Closing Price Updated: 7:00 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 606,027 Open 9.370 Bid (Size) 8.970 (1) Ask (Size) 9.660 (1) Prev. Close 9.330 Today's Range 9.290 - 9.665 52wk Range 7.520 - 10.45 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Enfusion Announces Third Quarter 2024 Results November 04, 2024 From Enfusion, Inc. Via Business Wire Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation October 10, 2024 From Enfusion, Inc. Via Business Wire Performance YTD -0.75% -0.75% 1 Month +4.61% +4.61% 3 Month +17.87% +17.87% 6 Month +0.43% +0.43% 1 Year +4.26% +4.26% More News Read More Enfusion Announces Date of Third Quarter 2024 Results October 03, 2024 From Enfusion, Inc. Via Business Wire A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts March 13, 2024 Via Benzinga Earnings Outlook For Enfusion March 11, 2024 Via Benzinga ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm September 04, 2024 From The Schall Law Firm Via Business Wire Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings August 22, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings August 14, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm August 10, 2024 From The Schall Law Firm Via Business Wire ENFN Stock Earnings: Enfusion Misses EPS, Misses Revenue for Q2 2024 August 06, 2024 Via InvestorPlace Enfusion Announces Second Quarter 2024 Results August 06, 2024 From Enfusion, Inc. Via Business Wire Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility August 02, 2024 From Enfusion, Inc. Via Business Wire Enfusion Announces Date of Second Quarter 2024 Results July 16, 2024 From Enfusion, Inc. Via Business Wire Enfusion To Present at Upcoming Investor Events May 29, 2024 From Enfusion, Inc. Via Business Wire ENFN Stock Earnings: Enfusion Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Enfusion Announces First Quarter 2024 Results May 09, 2024 From Enfusion, Inc. Via Business Wire Enfusion Announces Date of First Quarter 2024 Results April 18, 2024 From Enfusion, Inc. Via Business Wire The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024 April 04, 2024 Via InvestorPlace Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion March 21, 2024 From Enfusion Via Business Wire Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024 March 15, 2024 Via InvestorPlace 12 Information Technology Stocks Moving In Thursday's Pre-Market Session March 14, 2024 Via Benzinga Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results March 12, 2024 From Enfusion, Inc. Via Business Wire Wall Street's Top 10 Stock Calls This Week - Saturday, March 2 March 02, 2024 Via Talk Markets Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock February 28, 2024 Via Benzinga Earnings Scheduled For March 12, 2024 March 12, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
